Statement of Comprehensive Income
Comprehensive income is the change in equity (net assets) of a business enterprise during a period from transactions and other events and circumstances from non-owners sources. It includes all changes in equity during a period except those resulting from investments by owners and distributions to owners.
Paying user area
Try for free
Cytokinetics Inc. pages available for free this week:
- Balance Sheet: Assets
- Balance Sheet: Liabilities and Stockholders’ Equity
- Common Stock Valuation Ratios
- Enterprise Value to EBITDA (EV/EBITDA)
- Present Value of Free Cash Flow to Equity (FCFE)
- Selected Financial Data since 2005
- Operating Profit Margin since 2005
- Current Ratio since 2005
- Debt to Equity since 2005
- Price to Book Value (P/BV) since 2005
The data is hidden behind: . Unhide it.
Get full access to the entire website from $10.42/mo, or
get 1-month access to Cytokinetics Inc. for $22.49.
This is a one-time payment. There is no automatic renewal.
We accept:
Cytokinetics Inc., consolidated statement of comprehensive income
US$ in thousands
Based on: 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31).
- Net Loss
- The net loss exhibits a clear upward trend, increasing substantially each year from 2018 to 2022. Starting at approximately -106 million USD in 2018, the loss grows to nearly -389 million USD by 2022. Notably, the net loss accelerates in 2021 and 2022, with the loss in 2022 being almost double that in 2021.
- Unrealized Gain (Loss) on Available-for-Sale Securities
- This item shows minor positive unrealized gains in 2018 and 2019 but reverses to negative unrealized losses starting in 2020. The losses deepen over time, reaching approximately -2.7 million USD by 2022. This indicates a deteriorating value of the available-for-sale securities over the observed period.
- Other Comprehensive Income (Loss)
- The pattern of other comprehensive income (loss) matches the unrealized gains/losses on available-for-sale securities exactly, indicating that this component is the sole determinant of other comprehensive income or loss. It shifts from positive in early years (2018, 2019) to increasing losses in later years (2020-2022).
- Comprehensive Loss
- The comprehensive loss combines the net loss with other comprehensive income (loss), resulting in increasingly negative values over the period. It grows from approximately -106 million USD in 2018 to nearly -392 million USD in 2022. The pattern closely mirrors that of the net loss, with incremental negative impact from the increasing unrealized losses in securities investments.